Study of Huperzine A Sustained-Release Tablets in Patients With Alzheimer's Disease
Clinical trial NCT01282619 · UNKNOWN
Trial details
- NCT number
- NCT01282619
- Sponsor
- Shandong Luye Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-05-01
- Primary completion
- 2012-06-01
- Enrollment
- 390
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.